dc.contributor.author | Couladouros, EA | en |
dc.contributor.author | Soufli, IC | en |
dc.date.accessioned | 2014-06-06T06:42:59Z | |
dc.date.available | 2014-06-06T06:42:59Z | |
dc.date.issued | 1995 | en |
dc.identifier.issn | 00404039 | en |
dc.identifier.uri | http://62.217.125.90/xmlui/handle/123456789/931 | |
dc.relation.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-0028822734&partnerID=40&md5=af45f9b44561d69121a17d064582d5cf | en |
dc.subject.other | antineoplastic agent | en |
dc.subject.other | combretastatin d1 | en |
dc.subject.other | macrocyclic compound | en |
dc.subject.other | unclassified drug | en |
dc.subject.other | article | en |
dc.subject.other | drug synthesis | en |
dc.subject.other | reaction analysis | en |
dc.subject.other | stereochemistry | en |
dc.title | Total synthesis of natural (-)-combretastatin D-1 | en |
heal.type | journalArticle | en |
heal.publicationDate | 1995 | en |
heal.abstract | Combretastatin D-1, (2), was synthesized via a 12 step sequence. Sharpless asymmetric dihydroxylation was used in order to introduce the appropriate asymmetry. Regiospecific cyclodehydration of the diol 3 gave the title compound in 96% ee. | en |
heal.journalName | Tetrahedron Letters | en |
dc.identifier.issue | 51 | en |
dc.identifier.volume | 36 | en |
dc.identifier.spage | 9369 | en |
dc.identifier.epage | 9372 | en |
Αρχεία | Μέγεθος | Μορφότυπο | Προβολή |
---|---|---|---|
Δεν υπάρχουν αρχεία που σχετίζονται με αυτό το τεκμήριο. |